BRAND COLLECTION

Limelight Unveils Navarambh Bridal Line with Shilpa Shetty

Published: October 1, 2025
Author: Fashion Value Chain

Limelight Lab Grown Diamonds, India’s largest lab-grown diamond brand, has launched Navarambh, a new bridal jewellery collection unveiled through a campaign film featuring brand ambassador and investor Shilpa Shetty.

The collection is presented in an elegant keepsake box and includes seven versatile, modern, and timeless diamond pieces designed to accompany brides beyond their wedding day. From Karwa Chauth dinners to cocktail parties, Diwali festivities to anniversaries, Navarambh celebrates love and new beginnings by redefining bridal jewellery as part of everyday life.

“Navarambh is truly special! It is for the bride who carries a new vision and embraces every moment with grace and style. It’s jewellery that is timeless yet practical, a treasure she can wear on multiple occasions, making it the perfect gift for the start of her new journey,” said Shilpa Shetty.

Pooja Sheth Madhavan, Founder & Managing Director, added: “With Navarambh, we wanted to design jewellery that resonates with the aspirations of today’s bride — versatile, elegant, and meaningful. It’s more than jewellery; it’s a celebration of her individuality and milestones.”

Rupali Shrivastava, Chief Marketing Officer, emphasized: “Our most extensive campaign yet spans digital, print, television, and in-store experiences, showcasing how Navarambh is the practical choice for the modern bride.”

To mark the festive season, Limelight has also launched its Annual Bash Sale, offering Flat 30% OFF on Diamond Value and 100% OFF on Making Charges across all stores. With prices starting at ₹5.99 lakh, Navarambh is available across 50+ Limelight stores in 45+ cities.

Related Posts

APD Leads Large-Scale Accessibility Audit Drive on IDPD 2025

Syndicate Finance Expands Debt-Based Funding Solutions to Drive Business Growth

Pristyn Care Reports Robust Financial Growth in FY 23-24, Operating Revenue Jumps 33 percent, Aims for Profitability by FY 26

ALARM 2024: Amrita Leads the Fight Against Antimicrobial Resistance